Psilocybin mushrooms, colloquially known as magic mushrooms or shrooms, are fungi containing psilocybin and psilocin — naturally occurring psychedelic compounds of the tryptamine class. Upon ingestion, psilocybin is rapidly dephosphorylated to psilocin, which acts as a partial agonist at serotonin 5-HT2A receptors, producing profound alterations in perception, cognition, and emotion. Over 200 species of mushrooms contain psilocybin, with Psilocybe cubensis being the most commonly cultivated and used worldwide.
Psilocybin mushrooms have a long history of ceremonial and spiritual use among indigenous peoples of Mesoamerica and are among the most widely used psychedelics globally. Research beginning in the 1950s and experiencing a renaissance in the 2000s has established psilocybin as a clinically promising treatment for depression, anxiety, addiction, and end-of-life distress. The Johns Hopkins Center for Psychedelic and Consciousness Research and Imperial College London have published landmark trials demonstrating significant, lasting antidepressant effects from one or two supervised psilocybin sessions.
Unlike most classical psychedelics, psilocybin mushrooms are consumed in their natural form — dried or fresh fungal material — giving the experience a distinctly organic character that users frequently describe as warmer and more emotionally connected than synthetic psychedelics. The experience is highly dose-dependent: low doses produce euphoria and perceptual enhancement; higher doses can produce complete ego dissolution, mystical-type experiences, and confrontation with deeply held beliefs and emotions. Set and setting are universally recognized as the primary determinants of experience quality.
Psilocybin mushrooms have an exceptionally low acute toxicity profile and are considered physiologically safe. There are no confirmed human fatalities from psilocybin toxicity alone. The primary risks are psychological: anxiety, panic, or disturbing content during the experience, and rare cases of persisting perceptual disturbances (HPPD). Oregon and Colorado have legalized supervised psilocybin services; several cities have decriminalized personal possession.
